SBC Medical Group Holdings Incorporated (SBC)
NASDAQ: SBC · Real-Time Price · USD
3.380
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EDT - Market closed
SBC Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Revenue | 173.61 | 205.42 | 193.54 | 174.16 |
| Revenue Growth (YoY) | -15.48% | 6.13% | 11.13% | - |
| Cost of Revenue | 46.32 | 49.37 | 56.24 | 82.16 |
| Gross Profit | 127.28 | 156.05 | 137.3 | 92 |
| Selling, General & Admin | 58.86 | 57.07 | 64.33 | 70.09 |
| Other Operating Expenses | 0.94 | 0.6 | 2.31 | 1.54 |
| Operating Expenses | 59.8 | 70.69 | 66.64 | 71.63 |
| Operating Income | 67.49 | 85.36 | 70.66 | 20.37 |
| Interest Expense | -0.16 | -0.03 | -0.05 | -0.03 |
| Interest & Investment Income | 0.2 | 0.02 | 0.09 | 0.47 |
| Currency Exchange Gain (Loss) | 2 | 0.9 | - | - |
| Other Non Operating Income (Expenses) | 3.68 | 1.6 | 2.65 | 3.88 |
| EBT Excluding Unusual Items | 73.21 | 87.85 | 73.36 | 24.69 |
| Impairment of Goodwill | - | - | - | -0.25 |
| Gain (Loss) on Sale of Investments | 0.11 | -3.15 | 0.22 | -0.76 |
| Gain (Loss) on Sale of Assets | - | 3.81 | - | - |
| Asset Writedown | - | -15.06 | - | - |
| Other Unusual Items | 8.75 | - | - | - |
| Pretax Income | 82.07 | 73.46 | 73.58 | 23.68 |
| Income Tax Expense | 31.02 | 26.77 | 35.02 | 18.12 |
| Earnings From Continuing Operations | 51.05 | 46.69 | 38.56 | 5.55 |
| Minority Interest in Earnings | -0.06 | -0.08 | 0.81 | 0.76 |
| Net Income | 50.99 | 46.61 | 39.37 | 6.32 |
| Net Income to Common | 50.99 | 46.61 | 39.37 | 6.32 |
| Net Income Growth | 9.38% | 18.40% | 523.44% | - |
| Shares Outstanding (Basic) | 103 | 97 | 94 | 8 |
| Shares Outstanding (Diluted) | 103 | 97 | 94 | 8 |
| Shares Change (YoY) | 6.67% | 2.51% | 1084.96% | - |
| EPS (Basic) | 0.50 | 0.48 | 0.42 | 0.79 |
| EPS (Diluted) | 0.50 | 0.48 | 0.42 | 0.79 |
| EPS Growth | 2.54% | 15.50% | -47.39% | - |
| Free Cash Flow | 22.3 | 17.17 | 41.15 | -24.99 |
| Free Cash Flow Per Share | 0.22 | 0.18 | 0.44 | -3.14 |
| Gross Margin | 73.32% | 75.97% | 70.94% | 52.83% |
| Operating Margin | 38.87% | 41.56% | 36.51% | 11.70% |
| Profit Margin | 29.37% | 22.69% | 20.34% | 3.63% |
| Free Cash Flow Margin | 12.84% | 8.36% | 21.26% | -14.35% |
| EBITDA | 70.17 | 89.16 | 82.91 | 26.3 |
| EBITDA Margin | 40.42% | 43.41% | 42.84% | 15.10% |
| D&A For EBITDA | 2.68 | 3.8 | 12.25 | 5.93 |
| EBIT | 67.49 | 85.36 | 70.66 | 20.37 |
| EBIT Margin | 38.87% | 41.56% | 36.51% | 11.70% |
| Effective Tax Rate | 37.80% | 36.44% | 47.59% | 76.55% |
| Revenue as Reported | 173.61 | 205.42 | 193.54 | 174.16 |
| Advertising Expenses | 3.12 | 2.78 | 3.37 | 6.57 |
Source: S&P Capital IQ. Standard template. Financial Sources.